☰

Eachan O. Johnson - Publications

Affiliations: 
2014- Harvard University, Cambridge, MA, United States 
 2021- The Francis Crick Institute, London, England, United Kingdom 
Tree Info Similar researchers PubMed Report error

13/16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Nimmo C, Millard J, Faulkner V, Monteserin J, Pugh H, Johnson EO. Evolution of drug resistance in the genomic era. Frontiers in Cellular and Infection Microbiology. 12: 954074. PMID 36275027 DOI: 10.3389/fcimb.2022.954074  0.27
2021 Johnson EO, Hung DT. Using Proteolytic Hypomorphs to Detect Small Molecule Mechanism of Action. Methods in Molecular Biology (Clifton, N.J.). 2314: 323-342. PMID 34235661 DOI: 10.1007/978-1-0716-1460-0_15  0.543
2019 Johnson EO, Office E, Kawate T, Orzechowski M, Hung DT. A large-scale chemical-genetic strategy enables design of antimicrobial combination chemotherapy in . Acs Infectious Diseases. PMID 31721551 DOI: 10.1021/Acsinfecdis.9B00373  0.574
2019 Johnson EO, Hung DT. A point of inflection and reflection on systems chemical biology. Acs Chemical Biology. PMID 31613592 DOI: 10.1021/Acschembio.9B00714  0.555
2019 Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N, Delano K, Da Silva I, Davis J, Gallo C, Gardner M, et al. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature. PMID 31217586 DOI: 10.1038/S41586-019-1315-Z  0.571
2016 Johnson EO, Wong LL. Partial fusion of a cytochrome P450 system by carboxy-terminal attachment of putidaredoxin reductase to P450cam (CYP101A1). Catalysis Science & Technology. 6: 7549-7560. PMID 28944003 DOI: 10.1039/C6Cy01042C  0.622
2012 Bell SG, McMillan JH, Yorke JA, Kavanagh E, Johnson EO, Wong LL. Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity. Chemical Communications (Cambridge, England). 48: 11692-4. PMID 23104016 DOI: 10.1039/C2Cc35968E  0.662
2012 Boehringer J, Riedinger C, Paraskevopoulos K, Johnson EO, Lowe ED, Khoudian C, Smith D, Noble ME, Gordon C, Endicott JA. Structural and functional characterization of Rpn12 identifies residues required for Rpn10 proteasome incorporation. The Biochemical Journal. 448: 55-65. PMID 22906049 DOI: 10.1042/BJ20120542  0.338
2012 Bell SG, Yang W, Tan AB, Zhou R, Johnson EO, Zhang A, Zhou W, Rao Z, Wong LL. The crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding site. Dalton Transactions (Cambridge, England : 2003). 41: 8703-14. PMID 22695988 DOI: 10.1039/C2Dt30783A  0.66
2010 Bell SG, Tan AB, Johnson EO, Wong LL. Selective oxidative demethylation of veratric acid to vanillic acid by CYP199A4 from Rhodopseudomonas palustris HaA2. Molecular Biosystems. 6: 206-14. PMID 20024082 DOI: 10.1039/B913487E  0.66
2010 Bell SG, Xu F, Johnson EO, Forward IM, Bartlam M, Rao Z, Wong LL. Protein recognition in ferredoxin-P450 electron transfer in the class I CYP199A2 system from Rhodopseudomonas palustris. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 15: 315-28. PMID 19904564 DOI: 10.1007/S00775-009-0604-7  0.67
2009 Xu F, Bell SG, Peng Y, Johnson EO, Bartlam M, Rao Z, Wong LL. Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris. Proteins. 77: 867-80. PMID 19626710 DOI: 10.1002/Prot.22510  0.656
2009 Xu F, Bell SG, Peng Y, Johnson EO, Bartlam M, Rao Z, Wong L. Correction to the article “Crystal Structure of a Ferredoxin Reductase for the CYP199A2 System from Rhodopseudomonas palustris ” Proteins: Structure, Function, and Bioinformatics. 78: 501-501. DOI: 10.1002/Prot.22627  0.595
Low-probability matches (unlikely to be authored by this person)
2023 El Bakali J, Blaszczyk M, Evans JC, Boland JA, McCarthy WJ, Fathoni I, Dias MVB, Johnson EO, Coyne AG, Mizrahi V, Blundell TL, Abell C, Spry C. Chemical Validation of Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference. Angewandte Chemie (Weinheim An Der Bergstrasse, Germany). 135: e202300221. PMID 38515507 DOI: 10.1002/ange.202300221  0.247
2023 El Bakali J, Blaszczyk M, Evans JC, Boland JA, McCarthy WJ, Fathoni I, Dias MVB, Johnson EO, Coyne AG, Mizrahi V, Blundell TL, Abell C, Spry C. Chemical Validation of Mycobacterium tuberculosis Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference. Angewandte Chemie (International Ed. in English). PMID 36757665 DOI: 10.1002/anie.202300221  0.231
2024 Parkhill SL, Johnson EO. Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery. The Biochemical Journal. 481: 839-864. PMID 38958473 DOI: 10.1042/BCJ20220062  0.175
Hide low-probability matches.